Kistler-Tiffany Companies’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-79
| Closed | – | – | 653 |
|
|
2020
Q1 | $0 | Hold |
79
| – | – | ﹤0.01% | 578 |
|
|
2019
Q4 | $0 | Hold |
79
| – | – | ﹤0.01% | 609 |
|
|
2019
Q3 | $0 | Hold |
79
| – | – | ﹤0.01% | 615 |
|
|
2019
Q2 | $0 | Hold |
79
| – | – | ﹤0.01% | 604 |
|
|
2019
Q1 | $0 | Hold |
79
| – | – | ﹤0.01% | 596 |
|
|
2018
Q4 | $0 | Hold |
79
| – | – | ﹤0.01% | 599 |
|
|
2018
Q3 | $0 | Hold |
79
| – | – | ﹤0.01% | 599 |
|
|
2018
Q2 | $0 | Hold |
79
| – | – | ﹤0.01% | 634 |
|
|
2018
Q1 | $0 | Hold |
79
| – | – | ﹤0.01% | 611 |
|
|
2017
Q4 | $0 | Hold |
79
| – | – | ﹤0.01% | 598 |
|
|
2017
Q3 | $0 | Hold |
79
| – | – | ﹤0.01% | 592 |
|
|
2017
Q2 | $0 | Hold |
79
| – | – | ﹤0.01% | 552 |
|
|
2017
Q1 | $0 | Hold |
79
| – | – | ﹤0.01% | 555 |
|
|
2016
Q4 | $0 | Hold |
79
| – | – | ﹤0.01% | 581 |
|
|
2016
Q3 | $0 | Hold |
79
| – | – | ﹤0.01% | 770 |
|
|
2016
Q2 | $0 | Hold |
79
| – | – | ﹤0.01% | 789 |
|
|
2016
Q1 | $0 | Hold |
79
| – | – | ﹤0.01% | 626 |
|
|
2015
Q4 | $0 | Hold |
79
| – | – | ﹤0.01% | 660 |
|
|
2015
Q3 | $0 | Hold |
79
| – | – | ﹤0.01% | 656 |
|
|
2015
Q2 | $0 | Hold |
79
| – | – | ﹤0.01% | 666 |
|
|
2015
Q1 | $0 | Hold |
79
| – | – | ﹤0.01% | 652 |
|
|
2014
Q4 | $0 | Hold |
79
| – | – | ﹤0.01% | 667 |
|
|
2014
Q3 | $0 | Hold |
79
| – | – | ﹤0.01% | 761 |
|
|
2014
Q2 | $0 | Hold |
79
| – | – | ﹤0.01% | 725 |
|
|
2014
Q1 | $0 | Hold |
79
| – | – | ﹤0.01% | 598 |
|
|
2013
Q4 | $0 | Hold |
79
| – | – | ﹤0.01% | 601 |
|
|
2013
Q3 | $0 | Hold |
79
| – | – | ﹤0.01% | 623 |
|
|
2013
Q2 | $0 | Buy |
+79
| New | +$139 | ﹤0.01% | 605 |
|
Kistler-Tiffany Companies's GCVRZ Position: Q2 2020 in Review
Kistler-Tiffany Companies sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2020, closing a stake of 79 shares.
Kistler-Tiffany Companies first reported a position in GCVRZ in Q2 2013 and held it in 28 quarters. The position peaked at $0 in Q1 2020. 1 fund tracked by Wall St. Rank holds GCVRZ as of Q2 2020.
- Kistler-Tiffany Companies reported no remaining Sanofi Contingent Value Rights position as of Q2 2020 after selling out during the quarter.
- Kistler-Tiffany Companies sold 79 Sanofi Contingent Value Rights shares in Q2 2020.
- Kistler-Tiffany Companies first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 28 quarters.
- Kistler-Tiffany Companies's Sanofi Contingent Value Rights position peaked at $0 in Q1 2020.
- 1 fund tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2020.
Based on Kistler-Tiffany Companies's 13F filing for Q2 2020, filed 20 Jul 2020.